Helmerich & Payne, Inc. (HP): what the price assumes

boothcheck covers Helmerich & Payne, Inc. (HP) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed 2026-06-27.

Generated: 2026-07-29 · Exported: 2026-08-01 · Source: https://boothcheck.com/report/HP

Headline

FieldValue
TickerHP
CompanyHelmerich & Payne, Inc.
Current price$33.44/sh
CompositionNorth America Solutions 64% / International Solutions 22% / Offshore Solutions 14%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin (value-band context)8.3%
Operating margin (mid-cycle)27.9%
Margin compression (value-band)-19.6pp
Trailing margin (depressed year)-5.7%
Multiple paid5x mid-cycle operating income

The operating-margin figure is value-band context at year 7: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

The price sits below what even a 5%/yr operating-profit decline would warrant; the inversion reports a bound, not a solved growth path.

Solve inputs: computed at a 7.8% cost of capital with 4% terminal growth over a 5-year stage.

How unusual the bet is: within-range (limited comparison data)

ReferenceValue
vs own history+0.31σ
implied end-window share0%

Valuation X-Ray

The price is justified by relative-multiple and growth-DCF; earnings-power land below the price.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.39x2expensive
Earnings4.20x3expensive
Relative0.70x3justifies
Growth0.69x3justifies

Families that justify the price: Relative, Growth Families that call it expensive: Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 6.0%); the inversion above states its own rate.

Per-Model Detail (n=11)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth——no—
DCF Exit MultipleGrowth$55.650.60xyesExit EV/EBITDA: 5.5x / 10.5x / 15.5x (bear / base = today's held flat / bull), 5yr
Relative ValuationRelative$48.080.70xyesP/S fallback (negative EPS): Sector P/S 1.2x × TTM revenue — excluded from consensus
Simple DDMGrowth$3.609.29xyesDPS $1.02, g=-14.8% (sustainable: ROE (TTM) × retention; not the terminal-growth assumption), ke=9.3%
Two-Stage DDMGrowth$-12.57—noStage 1: -200% for 5yr, Stage 2: 3.5% perpetual
Simple Excess ReturnAsset$25.321.32xyesReference only (book value floor): BV/sh $25.32, ROE negative
Two-Stage Excess ReturnAsset$22.791.47xyesReference only (book value with convergence): BV/sh $25.32, ROE converges to ke
Discounted Future Market CapGrowth$48.330.69xyesRev $4.0B, growth 30% (input: historical growth; tapered), Terminal P/S: 0.6x / 0.8x / 1.0x (bear / base = today's held flat / bull, cap 6x)
Peter Lynch Fair ValueRelative$0.00—noNegative/zero EPS — earnings-based value floored at $0
Margin TrajectoryGrowth——no—
Earnings Power ValueEarnings$11.182.99xyesNormalized EBIT (5y avg op income, one-time charges added back) $0.23B × (1−21%) / WACC 6.0% → EPV (no growth)
Residual IncomeAsset——no—
Graham NumberAsset——no—
EV/EBITDA RelativeRelative$10.623.15xyesEBITDA $0.51B × sector EV/EBITDA 6.0x
FCF YieldEarnings$7.974.20xyesFCF $256.0M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings$4.048.28xyesSBC-adj FCF $0.22B (FCF $0.26B − SBC $0.04B) capitalized at Kₑ
Ben Graham FormulaEarnings——no—
ROIC-Justified P/BAsset——no—
P/Sales SectorRelative$48.080.70xyesRevenue $4.00B × sector P/S 1.2x
PEG Fair ValueRelative——no—
Earnings YieldEarnings——no—
Funds From Operations MultipleRelative——no—
Clinical Phase NPVGrowth——no—
MertonAsset——no—
V5 Mechanical———no—

Solvency

FieldValue
Net debt$1.8b
Net debt / NOPAT (after-tax)2.04x
Net debt / operating income (pre-tax)1.61x
Interest coverage10.3x
Share count CAGR (buyback)-1.3%
Burning cashno

Leverage and coverage are computed on normalized mid-cycle operating income (mid-cycle margin 27.9%); the trailing year was depressed.

Bullet Takeaways

Bull Case

Valuing a contract driller on its trailing earnings is a category error, because those earnings swing violently with the rig cycle and the latest quarter sits near the bottom of one. The honest lens is through-the-cycle economics, and on that basis Helmerich & Payne is cheap: the stock trades around 5 times normalized operating income, using the company's own mid-cycle margins on current revenue rather than the trough quarter. The bull case starts here, because the price assumes so little, it sits below what even a steady decline in operating profit would warrant.

The operating signal is that the cycle is turning. North America Solutions averaged 136 contracted rigs in the quarter, slightly ahead of expectations, and the company exited with 137 working and 138 active shortly after. Management said the second quarter likely marked the trough for North America rig count and margins, and it raised both its third-quarter and full-year rig outlook, now expecting 138 to 144 rigs for the year, as drilling demand improves. When the largest land driller calls the bottom and lifts guidance in the same breath, the trailing loss is the rear-view mirror, not the windshield.

The franchise quality supports the through-cycle case. H&P's FlexRig fleet commands premium day rates, and its contracts include early-termination protections; the 10-K notes a customer may cancel but may include an early termination payment to be paid to us if the contract is terminated prior to the expiration of the fixed term. That contractual structure cushions the downside that pure spot exposure would not. The company also carries a 34-year dividend track record and interest coverage above 10 times on normalized earnings, and it is deliberately deleveraging from the KCA Deutag acquisition before stepping up shareholder returns. The bull case is a high-quality, premium-fleet driller at a cyclical low, with management calling the trough and a path back to enhanced capital returns once the debt comes down.

Bear Case

The valuation methods disagree on Helmerich & Payne, and the disagreement is itself the bear's first point. On trailing earnings, the earnings-power lens reads the stock as expensive, because the company is currently losing money on an operating basis; only the relative-multiple and through-cycle growth approaches make it look cheap, and they do so by assuming a recovery to normalized margins. The cheap-versus-expensive split is the whole question: a buyer is paying a normalized-earnings price for a company that, right now, is not earning. If the mid-cycle assumption is too optimistic, the support disappears.

The international expansion is where the optimism is most exposed. The International Solutions segment posted an operating loss of nearly $100 million in the quarter, driven by the cost of reactivating rigs in Saudi Arabia and supply-chain disruption from Middle East conflict. That is the cost of the KCA Deutag acquisition showing up: H&P took on roughly $1.8 billion of net debt to expand internationally, and the early returns are losses rather than the diversification benefit the deal promised. A second-quarter adjusted net loss of $0.38 per share, far wider than the expected $0.06 loss, on revenue of $932 million that missed estimates, shows how badly the international drag is overwhelming the North American base.

The deeper bear point is the demand side, which H&P does not control. Its customers, the exploration and production companies, set drilling budgets against oil and gas prices, and the 10-K notes those producers have become more fiscally disciplined and that activity is dictated by capital budgets tied to current and expected future prices of crude oil and natural gas, which have historically been volatile. A producer base that prioritizes shareholder returns over volume growth is structurally less hungry for rigs than in past cycles, which can cap the recovery management is calling. The bear case is that the trough call is a forecast, the international integration is bleeding cash, the balance sheet now carries real debt, and the price already credits a mid-cycle recovery that disciplined customers may not fully deliver.

Valuation

Helmerich & Payne is the textbook case for why trailing earnings mislead on a cyclical. The most recent quarter is a trough, with an operating loss, so any multiple on trailing earnings is meaningless. The framework instead reads the price against the company's own through-the-cycle margins, around 28% normalized, applied to current revenue, and on that basis the stock trades near 5 times normalized operating income. That is a low number, low enough that the price sits below what even a steady decline in mid-cycle profit would warrant. The bet the price is making is simply that H&P returns to something like its normal earning power.

The families of method split exactly along the cyclical fault line. The relative-multiple and through-cycle growth lenses support the price; the earnings-power lens, anchored on the depressed trailing result, calls it expensive. That divergence is not a contradiction, it is the cycle: the static earnings lens sees the trough, the forward and peer lenses see the recovery. A buyer has to decide which is the better guide, and the answer hinges on whether the mid-cycle margin assumption holds and whether the international losses are temporary reactivation costs or a structural drag.

Solvency is the part that changed with the KCA Deutag deal and deserves weight. Net debt now sits near $1.8 billion, where before the acquisition H&P ran a far lighter balance sheet, and management has explicitly said enhanced shareholder returns wait until the deleveraging is further along. Interest coverage above 10 times on normalized earnings is comfortable, but that comfort depends on the normalized earnings actually materializing; on the current trough, coverage is far thinner. One measurement note: the trailing operating result is a sharp loss while the normalized figure the multiple uses is strongly positive, so the two are different bases and the 5-times read is explicitly a through-cycle solve, not a trailing fact. The valuation rests on the recovery being real and the international integration turning from cost to contribution.

Catalysts

The fiscal second-quarter 2026 report, released in early May, was a miss against a difficult backdrop. Helmerich & Payne posted an adjusted net loss of $0.38 per share, wider than the expected $0.06 loss, on revenue of $932 million that fell short of estimates, with adjusted EBITDA of $178 million landing toward the lower end of implied guidance. The damage was concentrated in International Solutions, which lost nearly $100 million on Saudi rig reactivation and Middle East supply-chain disruption, while North America Solutions held up better at 136 average contracted rigs.

The constructive forward signal was management's trough call. The company said the quarter likely marked the bottom for North America rig count and margins, and it raised guidance: third-quarter North America direct margins of $230 to $240 million on 137 to 143 rigs, and a full-year rig range lifted to 138 to 144. The key things to watch across the next two quarters are whether the North America rig count climbs as guided, whether the international segment's reactivation losses narrow as the Saudi rigs come online and the supply-chain disruption eases, and the pace of deleveraging, since the company has tied any step-up in shareholder returns to bringing the post-acquisition debt down.

Peer Cohorts (Per Segment, With Filing Citations)

North America Solutions (reported)

International Solutions (reported)

Offshore Solutions (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

fiscal Q2 2026 earnings call

View the full interactive HP report on boothcheck